Dr Angelique Coetzee, a private practitioner and chair of South African Medical Association, has said that symptoms of the Omicron variant were so far mild and could be treated at home, Reuters news agency reported on Monday.
She was one of the first to suspect a different coronavirus strain among patients.
Coetzee, who is also on the Ministerial Advisory Committee on Vaccines, said unlike the Delta variant, so far patients have not reported loss of smell or taste and there has been no major drop in oxygen levels with the new variant.
Also, her experience so far has been that the variant is affecting people who are 40 or younger.
Almost half of the patients with Omicron symptoms that she treated were not vaccinated.
"The most predominant clinical complaint is severe fatigue for one or two days. With them, the headache and the body aches and pain," she added.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine